Editorial
Published on 12 May 2026
Editorial: Case reports in psychopharmacology, volume IV
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1861985
- 664 views
Type at least 3 characters
635 articles
articles
Case Report
Accepted on 11 May 2026
"Homicide and Zonisamide": A Review of the Literature and Illustrative Case Report on Second and Third Generation Antiseizure Medications and Psychiatric Effects
in Psychopharmacology
Frontiers in Psychiatry
- 115 views
Systematic Review
Accepted on 07 May 2026
Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis
in Psychopharmacology
Frontiers in Psychiatry
- 219 views
Case Report
Published on 29 Apr 2026
Case report: Effective treatment of posttraumatic aggression in a child affected by TBI treated with long-acting injectable paliperidone: a case study and literature review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1772148
- 793 views
Case Report
Published on 27 Apr 2026
Case Report: Early onset pulmonary embolism following antipsychotic polypharmacy in an acute psychiatric setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1819958
- 685 views
Case Report
Published on 27 Apr 2026
Milnacipran continuation during pregnancy in a patient with severe post-traumatic stress disorder and psychotic depression: a case report with 3-year pediatric follow-up
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1830520
- 792 views
Case Report
Published on 21 Apr 2026
Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1819962
- 1,020 views
Original Research
Published on 20 Apr 2026
Electrocardiographic findings in children and adolescents treated with antipsychotics: a cohort study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1807504
- 735 views
Original Research
Published on 14 Apr 2026
Medical evaluation of first presentation of psychotic symptoms in children and adolescents
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1678974
- 646 views
Case Report
Published on 13 Apr 2026
Acute liver failure and hemolytic anemia induced by quetiapine and aripiprazole overdose in a patient with schizophrenia and metastatic breast cancer: a unique case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1782761
- 809 views
Original Research
Published on 10 Apr 2026
Mechanisms of Changma Xifeng tablet in alleviating Tourette syndrome via modulation of neurotransmitters, inflammatory responses, and metabolic pathways
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1773753
- 854 views
Original Research
Accepted on 06 Apr 2026
Gender-specific symptom outcomes on Cariprazine 12-month naturalistic longitudinal follow-up in schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
- 300 views
Case Report
Published on 31 Mar 2026
Case Report: Fluoxetine-induced leucocytoclastic vasculitis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1803583
- 609 views
- 1 citation
Hypothesis and Theory
Published on 17 Mar 2026
DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1751605
- 1,299 views
- 3 citations
Opinion
Published on 17 Mar 2026
Urgent response is needed to address the stimulant-fentanyl related overdose crisis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1769408
- 1,253 views
Review
Published on 16 Mar 2026
Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1766485
- 1,293 views
Case Report
Published on 16 Mar 2026
Case Report: A rare phenomenon of venlafaxine induced vocal tics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1797640
- 1,015 views
- 1 citation
Original Research
Published on 10 Mar 2026
Locomotor and endocrine alterations link to metabolic dysfunction induced by pathopharmacological interaction between neurodevelopmental disorders and antipsychotics: evidence from clinical and animal study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1764492
- 574 views
General Commentary
Published on 09 Mar 2026
Commentary: Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1807080
- 1,030 views
Mini Review
Published on 04 Mar 2026
Ketamine as an NMDA-modulating therapy in bipolar disorder: rationale and evidence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1777402
- 1,583 views
Editorial
Published on 03 Mar 2026
Editorial: COVID and psychotropics 2024: lessons learnt and future directions for research
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1800334
- 264 views
Case Report
Published on 18 Feb 2026
Reversible aripiprazole-induced tardive dyskinesia: a case series from Saudi Arabia and literature review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1749247
- 1,223 views
- 1 citation
Original Research
Published on 17 Feb 2026
Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1769162
- 763 views
Case Report
Published on 11 Feb 2026
Case Report: Atypical neuroleptic malignant syndrome induced by paliperidone palmitate—diagnostic challenges and clinical considerations
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2026.1718815
- 949 views
- 2 citations